Clinical trial
Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa…
NCT00419380 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00419380 |
|---|---|
| Title | Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®) |
| Official title | Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®) |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Otitis Media |
| Intervention type | Drug |
| Interventions | dornase alfa (Pulmozyme®) |
| Enrollment | 40 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Jan 8, 2007 |
| Last update posted | Mar 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: